Mutations affecting the binding of L-arginine (e.g., the Glu360Asp variant) and variants in noncoding regulatory regions of the NAGS gene have been shown to impair NAGS activity, thereby resulting in the NAGSD phenotype [74]. Here, NAGS is linked to hyperammonemia due to N-acetylglutamate synthase deficiency.